Distributors paying out millions for their part in opioid crisis
The three largest US drug distributors and a major generic-drug manufacturer have agreed to pay more than $250m (€225m) to settle the first federal trial over the companies’ role in fuelling the US opioid epidemic.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





